Status:
COMPLETED
Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women
Lead Sponsor:
Rio de Janeiro State University
Collaborating Sponsors:
Laboratory for Clinical and Experimental Research on Vascular Biology
Conditions:
1- Microvascular Function
2-oxidative Stress
Eligibility:
FEMALE
19-50 years
Phase:
PHASE4
Brief Summary
The prevalence of obesity and type 2 diabetes mellitus (T2DM) has increased progressively in the past decades, and consequently, a higher incidence of cardiovascular diseases is observed. As this proc...
Eligibility Criteria
Inclusion
- All patients should have BMI \> 30kg/m²
- Present untreated diabetes mellitus type 2
- Age between 19 and 50 years
- Waist Circumference \> 80 cm
Exclusion
- Renal, coronary vascular or peripheral, hematologic or hepatic disease
- Presence of severe hypertriglyceridemia (\> 400mg/dl)
- Smokers
- Significant body mass loss (\> 5%) within the six months prior to the study
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01827280
Start Date
April 1 2013
End Date
November 1 2016
Last Update
May 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory for Clinical and Experimental Research on Vascular Biology
Rio de Janeiro, Brazil, 20550-900